Instylla, Inc., a privately held company developing novel resorbable embolics for peripheral vascular embolization, today ...
HOUSTON -- Preoperative embolization of meningioma was associated with improved relapse-free survival (RFS) in a retrospective propensity-matched review. Surgery without embolization was associated ...
Instylla, Inc., a developer of resorbable embolics for peripheral vascular embolization, announced the completion of the ...
Los Angeles, CA – September 3, 2025 - Dr. Vadim Jucaud's lab at the Terasaki Institute has developed a human vascularized liver cancer-on-a-chip model to evaluate vessel remodeling and cell death in ...
Global Transcatheter Embolization and Occlusion Devices Market to Expand at 8.66% CAGR as Demand for Minimally Invasive Vascular and Cancer Therapies Accelerates.Austin, Texas, Jan. 27, 2026 (GLOBE ...
AMSTERDAM, the Netherlands — For patients with unresectable intermediate-stage hepatocellular carcinoma, selective internal radioembolization and standard transarterial chemoembolization provide ...
Professor Yu Li and the team combine embolization and resection in a single procedure for safer outcomes in hypervascular CNS tumors. Hypervascular tumors of the central nervous system (CNS), ...
Good afternoon, and welcome to the TriSalus Life Sciences Virtual KOL event. [Operator Instructions] As a reminder, this call is being recorded, and a replay will be made available on the TriSalus ...
Dr. Vadim Jucaud's lab at the Terasaki Institute has developed a human vascularized liver cancer-on-a-chip model to evaluate vessel remodeling and cell death in response to embolic agents. This novel ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results